Skip to content
drillr.ai
Sign up

CSCI

COSCIENS Biopharma Inc.

NASDAQ · Healthcare · Biotechnology · CA

$2.72
+0.00%
Ask drillr

  • Aug 11, 2026, 21:55 UTC

    COSCIENS Biopharma Inc. reported a net loss of $202,000 for its second quarter, with revenue of $3.1 million.

    Source: